Wells Fargo
PRVA icon

Wells Fargo’s Privia Health PRVA Stock Holding History

Wells Fargo’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Buy
146,095
+72,083
+97% +$1.67M ﹤0.01% 3102
2026
Q1 		$1.52M Sell
74,012
-78,528
-51% -$1.77M ﹤0.01% 3481
2025
Q4 		$3.62M Buy
152,540
+56,511
+59% +$1.38M ﹤0.01% 2969
2025
Q3 		$2.39M Sell
96,029
-4,541
-5% -$97.7K ﹤0.01% 3194
2025
Q2 		$2.31M Sell
100,570
-7,529
-7% -$174K ﹤0.01% 3120
2025
Q1 		$2.43M Buy
108,099
+59,429
+122% +$1.38M ﹤0.01% 3017
2024
Q4 		$951K Buy
48,670
+16,357
+51% +$324K ﹤0.01% 3745
2024
Q3 		$588K Sell
32,313
-906
-3% -$17.3K ﹤0.01% 3886
2024
Q2 		$577K Sell
33,219
-2,141
-6% -$37.9K ﹤0.01% 3821
2024
Q1 		$693K Buy
35,360
+4,536
+15% +$95.8K ﹤0.01% 3675
2023
Q4 		$710K Buy
30,824
+5,626
+22% +$126K ﹤0.01% 3636
2023
Q3 		$580K Sell
25,198
-62,224
-71% -$1.58M ﹤0.01% 3668
2023
Q2 		$2.28M Buy
87,422
+25,634
+41% +$677K ﹤0.01% 2790
2023
Q1 		$1.71M Buy
61,788
+14,647
+31% +$387K ﹤0.01% 2999
2022
Q4 		$1.07M Sell
47,141
-33,117
-41% -$922K ﹤0.01% 3202
2022
Q3 		$2.73M Buy
80,258
+49,436
+160% +$1.83M ﹤0.01% 2466
2022
Q2 		$897K Sell
30,822
-80,448
-72% -$2.05M ﹤0.01% 3354
2022
Q1 		$2.97M Buy
111,270
+17,975
+19% +$424K ﹤0.01% 2913
2021
Q4 		$2.41M Sell
93,295
-238,937
-72% -$5.96M ﹤0.01% 3301
2021
Q3 		$7.83M Buy
332,232
+157,928
+91% +$5.51M ﹤0.01% 2434
2021
Q2 		$7.73M Buy
+174,304
New +$6.43M ﹤0.01% 2452

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo's PRVA Position: Q2 2026 in Review

Wells Fargo increased its Privia Health (PRVA) stake by 97% in Q2 2026, buying an estimated $1.67M and bringing the position to 146,095 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

Wells Fargo first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.83M in Q3 2021. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Wells Fargo held 146,095 shares of Privia Health worth $3.76M as of Q2 2026.
  • Wells Fargo bought 72,083 Privia Health shares in Q2 2026, an estimated $1.67M.
  • Privia Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3102 holding.
  • Wells Fargo first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Wells Fargo's Privia Health position peaked at $7.83M in Q3 2021.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.